Navigation Links
Vanda Pharmaceuticals Reports First Quarter 2013 Results
Date:5/9/2013

llion. The total revenues for the first quarter of 2013 and 2012 each included $1.5 million in Fanapt® royalties received from Novartis.

Total operating expenses for the first quarter of 2013 were $12.3 million, compared to $16.5 million for the first quarter of 2012.  The primary driver of the lower expenses in the first quarter of 2013 was the completion of the tasimelteon Non-24 and Major Depressive Disorder efficacy studies.

Vanda recorded a net loss of $4.2 million for the first quarter of 2013, compared to a net loss of $8.0 million for the same period in 2012.  Diluted net loss per share for the first quarter of 2013 was $0.15, compared to a diluted net loss per share of $0.28 for the first quarter of 2012.

Cash decreased by $9.5 million in the first quarter of 2013, compared to decreases of $10.6 million in the first quarter of 2012 and $14.0 million in the fourth quarter of 2012.  Vanda's Cash as of March 31, 2013 totaled $110.9 million.First Quarter 2013 Key Financial Figures1Three Months EndedMarch 31December 31(in thousands, except per share amounts)  20132012  Change ($)Change (%)Total revenues

$
8,068$
7,920$
482%Research & development  expenses

7,96010,617(2,657)(25%)General & administrative expenses

3,9583,22573323%Non-cash stock-based compensation2

952923293%Net loss

(4,173)(6,369)2,19634%Diluted net loss per share

$
(0.15)$
(0.23)$
.0835% Select Cash Flow Data1 Three Months EndedMarch 31March 31(in thousands)20132012Net cash provided by (used in)  Operating activities

$
(9,125)$
(8,690)  Investing activities

30,47728,861Financing activities

(193)- Select Balance Sheet Data1 March 31December 31March 31(in thousands)201320122012Total cash and marketable securities$
,932$
20,403$

'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
2. Nieuwe behandeloptie vandaag geïntroduceerd voor artsen die patiënten behandelen met veelvuldig recidiverend of refractair agressief B-cel-non-hodgkinlymfoom
3. Vanda Pharmaceuticals to Present at the Lazard Healthcare Conference
4. Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare Conference
5. Adamis Pharmaceuticals CEO Provides Update for Shareholders
6. Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results
7. Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc.
8. VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
9. Aurigenes Collaboration Programs with Endo Pharmaceuticals Reach Important Milestones
10. Next Silicon Valley BioTalks Tackles “Is EDC Becoming a Commodity?” at Onyx Pharmaceuticals HQ
11. Global Nuclear Medicine / Radiopharmaceuticals Market worth $5.55 Billion by 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 2015 North Carolina-based life sciences ... Professor of Medicine, Mayo Clinic College of Medicine, ... Directors. , Entegrion’s Executive Chairman John ... have Dr. Noel, a distinguished physician and researcher ... Entegrion’s Board. His expertise in hematology and military ...
(Date:3/5/2015)... March 05, 2015 e2b teknologies ... Partner located in Northeast Ohio, today announced a leading ... to support its upgrade to the latest version of ... independent group practice of its kind in the region, ... volume of transactions, so efficiency and data accessibility are ...
(Date:3/4/2015)... 2015 The UPMC Center for Health Security ... the Emerging Leaders in Biosecurity Initiative (ELBI). As part ... field of biosecurity, UPMC has selected 28 US and ... of backgrounds, including biological science, medicine, policy, the military, ... "With the vision and support of the Defense Threat ...
(Date:3/4/2015)... CALGARY , March 4, 2015 /CNW/ ... that it has completed a collaborative research ... quantitative analytics.  Using Fast Collective Evolution Technology ... dataset including all measurements obtained from each ... Company,s Phase 2 clinical trials ASSERT, SUSTAIN ...
Breaking Biology Technology:Entegrion Announces Appointment of Pierre Noel, MD, to Its Board of Directors 2Physician Group Practice Chooses e2b teknologies to Support Its Upgrade to Sage 100 ERP 2014 2UPMC Center for Health Security Announces 2015 Emerging Leaders in Biosecurity 2UPMC Center for Health Security Announces 2015 Emerging Leaders in Biosecurity 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4
... and Collagen ... Stimulating Properties of Radiesse, SAN MATEO, Calif., June 26 ... publication of five studies in the,June 2008 issue of the ... of Dermatologic Surgery. The five,published clinical and preclinical reports were:, ...
... Shock Congress by sepsis thought ... ... Diagnostics Inc.,(TSX: SDI) today announced the presentation of data that demonstrates ... cleared diagnostic for the measurement of endotoxin, to,identify patients with elevated ...
... cattle feeders and dairymen industry wide with the creation of a revolutionary ... in the high moisture range without spoilage, rot or bad fermentation. ... ... Luthersville, GA has the attention of cattle feeders and dairymen industry wide ...
Cached Biology Technology:Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers 2Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers 3Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers 4Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers 5Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers 6Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics 2Breakthrough Slashes $7 Corn Over Half for Cattle Feeders 2Breakthrough Slashes $7 Corn Over Half for Cattle Feeders 3
(Date:2/24/2015)... 2015 This report analyzes the worldwide markets for Face ... Biometrics, and Voice Biometrics. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific , ... , and Latin America . Annual estimates and ... seven-year historic analysis is provided for these markets. Market data and ...
(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
(Date:2/9/2015)...  Lintec of America recently announced an exclusive license ... macrostructures, including sheets, yarns and ribbons, developed at the ... the vast industrial resources of the global Lintec Group, ... of America is forming the Nano-Science and Technology Center ... on scaling up the manufacturing and commercialization of nano ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... blueberries are a rich source of phytochemicals called polyphenols, which ... exert a wide array of protective health benefits. A new ... this growing body of evidence. This new ... and Metabolism , shows that regular long-term wild blueberry diets ...
... follows form" might have been written to describe proteins, ... nature,s workhorse biomolecules enables each to carry out its ... X-ray protein crystallography, in which a beam of x-rays ... protein,s atoms, creating a diffraction pattern of dots that ...
... of the western United States are one of the ... and hot, dry summers characterize these cold desert ecosystems ... published this week from MBL (Marine Biological Laboratory) senior ... their two former students, sheds light on how desert ...
Cached Biology News:Health benefits of wild blueberries abound: Study 2Bringing out the best in X-ray crystallography data 2Staying alive in the high and dry 2Staying alive in the high and dry 3
... The TUNEL-based assay kit provides complete components ... convenient detection of DNA fragmentation in cultured ... an one-step labeling of apoptotic cells. ... of apoptosis in mammalian cells. MBLs ApoDIRECT ...
... imaging system allows imaging of fluorescent and ... 46cm at a pixel size as low ... suitable for protein electrophoresis in the proteomics ... Fuji s FLA-5100 includes four imaging solutions ...
... high speed and excellent temperature uniformity. Protocols ... Thermocycler can be run without any modifications. ... block for 48 or 96 wells. In ... in-situ applications are available. The High Precision ...
... The Sciclone inL10 Workstation from Caliper represents ... offering for the first time the ability ... automatically react to changing conditions. In ... in viscosity due to changes in temperature, ...
Biology Products: